• Nem Talált Eredményt

IV. Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science

N/A
N/A
Protected

Academic year: 2022

Ossza meg "IV. Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science"

Copied!
1
0
0

Teljes szövegt

(1)

IV. Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science

January 19-21, 2022 - Szeged, Hungary

31 DOI: 10.14232/syrptbrs.2022.31

Nanofibers with probiotics combination for treatment of periodontal disease

Nina K. Grilc

1

, Julijana Kristl

1

, Tomaž Rijavec

2

, Aleš Lapanje

2

, Špela Zupančič

1

1 University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia

2 Jožef Stefan Institute, Department of Environmental Sciences, Ljubljana, Slovenia

Dysbiosis in the periodontal pocket represents the most detrimental factor in the development of periodontal disease [1]. Local administration of probiotic bacterial strains, especially autochthonous oral strains, into the periodontal region has shown to be a promising treatment option. Currently, there is a lack of appropriate systems for precise local delivery of probiotics into the periodontal pocket and thus, nanofibers present an excellent candidate [2,3]. Our work aims to develop nanofibers as a delivery system for a combination of two autochthonous oral bacterial strains.

We developed electrospun polyethylene oxide (PEO) and PEO-alginate nanofibers with incorporated individual probiotic strains and their combination. The probiotic Bacillus strains were isolated from a healthy oral cavity. Preservation of bacterial viability is crucial and was addressed by induction of bacterial sporulation prior to nanofiber fabrication. This strategy enabled high spore loading (> 7 logCFU/mg) with no significant decrease of bacterial viability.

The resulting nanofiber mats released viable spores in a sustained manner and PEO-alginate nanofibers exhibited a markedly slower release profile than PEO nanofibers.

The developed nanofibers with a combination of two potential probiotics showed the promising characteristics and will be further characterized based on their potential to inhibit the growth of pathogenic bacteria and elucidate the potential synergistic action of the two strains in combination.

References

1. Zidar et al. Expert Opin. Drug Deliv. 18(9), 1229-1244

2. Zupančič et al. Biomacromolecules. 19(11), 4299-430658 (2018) 3. Costalonga et al. Immunol. Lett. 162 (2): 22–38 (2014)

Hivatkozások

KAPCSOLÓDÓ DOKUMENTUMOK

3 Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.. 4 University of Chemistry

1 University of Szeged, Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, Szeged, Hungary.. 2 University of Szeged, Faculty of Pharmacy,

The zeta potential and vesicle size values were investigated, and furthermore, the possible correlation between various EOs with different concentrations was identified in

1 Medical University of Plovdiv, Faculty of Pharmacy, Department of Pharmaceutical Sciences, Plovdiv, Bulgaria.. 2 Medical University of Plovdiv, Faculty of Pharmacy,

SNEEDS have been widely investigated in recent years to improve the oral bioavailability of poorly water-soluble drugs, but it was also reported that these systems can address

In summary, the conducted study has revealed promising results which showed the possible pathways for further application of green extraction techniques in

My PhD work aims to formulate in situ gel-forming mucoadhesive eye drops containing dexamethasone-cyclodextrin inclusion complex to improve the residence time and solubility of

The aim of our study was to adapt the Analytical Quality by Design (AQbD) approach to design an effective in vitro release test method development using USP Apparatus IV